A gel technology system to determine postpartum RhIG dosage

Area of Science:

• Immunology
• Hematology
• Clinical Diagnostics

Background:

• Rh immune globulin (RhIG) prophylaxis is crucial for preventing RhD alloimmunization.
• Inadequate RhIG dosing due to inaccurate assessment of fetomaternal hemorrhage (FMH) can lead to treatment failures.
• The Kleihauer-Betke (K-B) test is the standard but can be time-consuming and subjective.

Purpose of the Study:

• To evaluate a novel gel technology (GT) method as a replacement for the K-B test in quantifying FMH.
• To assess the GT method's ability to guide RhIG dosage determination.
• To compare the efficiency and accuracy of the GT method against the K-B test.

Main Methods:

• Simulated FMH samples were created by mixing D+ cord blood with D- adult blood at varying volumes (10-40 mL).
• Samples were tested using the gel technology (GT) method involving incubation with anti-D, centrifugation, and supernatant titration.
• Results were compared with those obtained from the standard Kleihauer-Betke (K-B) test.

Main Results:

• The GT method provided easily discernible, reproducible results for determining RhIG dosage.
• Correlation between the GT method and the K-B test was confirmed.
• GT testing required 60 minutes for result availability with 30 minutes of direct technical time, offering significant time savings.

Conclusions:

• The gel technology (GT) method is a viable, objective, and quantitative alternative to the K-B test for assessing FMH.
• This technique aids in determining appropriate RhIG doses, potentially reducing costs and improving patient management.
• The GT system offers enhanced efficiency, objectivity, and speed in managing RhD-negative mothers with RhD-positive newborns.